Risk Factors for PONV in Patients Undergoing Hysteroscopic Surgery
NCT06524752 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1583
Last updated 2024-07-29
Summary
The purpose of this study was to construct and validate a risk prediction model for PONV in patients undergoing hysteroscopic day-case surgery.
Conditions
- Gynecologic Nursing
- Postoperative Complications
Interventions
- OTHER
-
The presence of nausea and vomiting within 24 hours after surgery
This is a prospective risk prediction model building, thus there is no traditional definition of intervention.
- OTHER
-
Non-existence of nausea and vomiting within 24 hours after surgery
This is a prospective risk prediction model building, thus there is no traditional definition of intervention.
Sponsors & Collaborators
-
Weifang Medical University
lead OTHER
Principal Investigators
-
Shirong Fang, Researcher · Weifang People's Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-01
- Primary Completion
- 2024-01-01
- Completion
- 2024-06-01
Countries
- China
Study Locations
More Related Trials
-
The Effect of Combining Aprepitant With Ondansetron in High-risk Patients for Postoperative Nausea and Vomiting
NCT01897337 ·Status: COMPLETED ·Phase: PHASE4
-
Risk Factors for Postoperative Nausea/Vomiting
NCT02944942 ·Status: COMPLETED
-
Opioid-free Anesthesia in Gynecologic Surgery
NCT04700761 ·Status: UNKNOWN ·Phase: NA
-
Prevention of Post-Operative Nausea and Vomiting With Propofol Infusion
NCT05759481 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in PONV
NCT06170476 ·Status: COMPLETED ·Phase: NA
-
Predictive Model for PONV for Patient Received Gynecological Laparoscopic Surgery
NCT05757986 ·Status: UNKNOWN
-
Comparison of the Effect of Ondansetron and Combined Ondansetron and Betahistine on Postoperative Nausea and Vomiting After Gynecological Laparoscopy
NCT02026778 ·Status: COMPLETED ·Phase: NA
-
Intravenous Versus Intraperitoneal Instillation of Ondansetron for Decreasing Incidence of Nausea and Vomiting After Laparoscopic Gynecological Surgeries.
NCT05317611 ·Status: COMPLETED ·Phase: NA
-
Prevalence and Associated Factors of Post-operative Nausea and Vomiting
NCT05970055 ·Status: COMPLETED
-
Incidence and Factors Associated With PONV in Regional Anaesthesia
NCT03835234 ·Status: COMPLETED
-
Continuous Infusion of Palonosetron for Preventing of Postoperative Nausea and Vomiting
NCT01482468 ·Status: UNKNOWN ·Phase: NA
-
Prevention Post Operative Nausea Vomiting in Ambulatory Gynecologic Laparoscopy
NCT01543945 ·Status: COMPLETED ·Phase: PHASE2
-
Risk Factors Analysis for Clinical Important Postoperative Nausea and Vomiting
NCT06445920 ·Status: COMPLETED
-
Effect of Intravenous Dextrose on PONV in Patients Undergoing Gynecological Laparoscopy
NCT05932160 ·Status: RECRUITING ·Phase: NA
-
Propofol Versus Dexmedetomidine on the Incidence of Postoperative Nausea and Vomiting
NCT05875077 ·Status: UNKNOWN ·Phase: NA
-
Intrathecal Atropine Versus Intravenous Ondasetron in Post Operative Nausea Due to Intrathecal Morphine
NCT05137288 ·Status: UNKNOWN ·Phase: NA
-
Early PONV - a Registry Based Study in Sweden.
NCT04433676 ·Status: UNKNOWN
-
Intravenous Versus Intra-peritoneal Dexamethasone on the Incidence of Postoperative Nausea and Vomiting
NCT02947672 ·Status: COMPLETED ·Phase: NA
-
Effects of taVNS Combined With Dexmedetomidine on POVN
NCT07271147 ·Status: RECRUITING ·Phase: NA
-
the Effect of Three Different Analgesic Techniques on the Incidence of Postoperative Nausea and Vomiting
NCT03313479 ·Status: UNKNOWN
-
Effect of Lidocaine Plus Dexmedetomidine Infusion on PONV
NCT03788018 ·Status: COMPLETED ·Phase: NA
-
Prophylactic Antiemetic Efficacy of Palonosetron Versus Ondansetron for Cesarean Sections Under Regional Anesthesia
NCT02468323 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of SmtO2 Guided Care on PONV (iMODIPONV)
NCT03641625 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate Anxiety Sensitivity and Somatic Symptoms as Risk Factors for PONV
NCT01875120 ·Status: COMPLETED
-
The Opioid-sparing Effect and Reduced PONV Using Propacetamol in PCA Among Patients With High Risk of PONV
NCT02116257 ·Status: COMPLETED ·Phase: NA